Cite
HARVARD Citation
Montecucco, F. et al. (2015). Anti-apoA-1 autoantibodies increase mouse atherosclrotic plaque vulnerability, myocardial necrosis and mortality trough TLR2 and TLR4-mediated pathways. Atherosclerosis. 241 (1), pp. e27-. [Online].